BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 9563643)

  • 1. Differential expression of protein kinase C isoforms in diethylnitrosamine-initiated rat liver.
    Lee YS; Hong SI; Lee MJ; Kim MR; Jang JJ
    Cancer Lett; 1998 Apr; 126(1):17-22. PubMed ID: 9563643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of calcium-dependent protein kinase C isoforms in the early stages of diethylnitrosamine-induced rat hepatocarcinogenesis.
    La Porta CA; Perletti GP; Piccinini F; Comolli R
    Mol Carcinog; 1993; 8(4):255-63. PubMed ID: 7904165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Over-expression of protein kinase C delta is associated with a delay in preneoplastic lesion development in diethylnitrosamine-induced rat hepatocarcinogenesis.
    La Porta CA; Comolli R
    Carcinogenesis; 1995 May; 16(5):1233-8. PubMed ID: 7767990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased protein kinase C activity in myotrophin-induced myocyte growth.
    Sil P; Kandaswamy V; Sen S
    Circ Res; 1998 Jun; 82(11):1173-88. PubMed ID: 9633917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in protein kinase C alpha, delta and in nuclear beta isoform expression in tumour and lung metastatic nodules induced by diethylnitrosamine in the rat.
    La Porta CA; Tessitore L; Comolli R
    Carcinogenesis; 1997 Apr; 18(4):715-9. PubMed ID: 9111205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane and nuclear protein kinase C activation in the early stages of diethylnitrosamine-induced rat hepatocarcinogenesis.
    La Porta CA; Comolli R
    Carcinogenesis; 1994 Aug; 15(8):1743-7. PubMed ID: 8055657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aryl sulfotransferase IV deficiency in rat liver carcinogenesis initiated with diethylnitrosamine and promoted with N-2-fluorenylacetamide or its C-9-oxidized metabolites.
    Malejka-Giganti D; Ringer DP; Vijayaraghavan P; Kiehlbauch CC; Kong J
    Exp Mol Pathol; 1997 Apr; 64(2):63-77. PubMed ID: 9316585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in protein kinase C isoforms in experimentally-induced colitis in the rat.
    Chang Q; Soper BD; Yacyshyn BR; Tepperman BL
    Inflamm Res; 2000 Jan; 49(1):27-35. PubMed ID: 10778918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase C isoforms in human and rat colonic mucosa.
    Davidson LA; Jiang YH; Derr JN; Aukema HM; Lupton JR; Chapkin RS
    Arch Biochem Biophys; 1994 Aug; 312(2):547-53. PubMed ID: 8037470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ischemic preconditioning induces selective translocation of protein kinase C isoforms epsilon and eta in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity.
    Ping P; Zhang J; Qiu Y; Tang XL; Manchikalapudi S; Cao X; Bolli R
    Circ Res; 1997 Sep; 81(3):404-14. PubMed ID: 9285643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of protein kinase C isoform-specific expression during rat hepatocarcinogenesis after exposure to the peroxisome proliferator WY-14,643.
    Corton JC; Swanson C; Miller RT; Cattley RC
    Cancer Lett; 1999 Mar; 137(1):9-15. PubMed ID: 10376789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell proliferation and hepatocarcinogenesis in rat initiated by diethylnitrosamine and promoted by phenobarbital: potential roles of early DNA damage and liver metallothionein expression.
    Chakraborty T; Chatterjee A; Rana A; Srivastawa S; Damodaran S; Chatterjee M
    Life Sci; 2007 Jul; 81(6):489-99. PubMed ID: 17651763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase C isoforms epsilon, eta, delta and zeta in murine adipocytes: expression, subcellular localization and tissue-specific regulation in insulin-resistant states.
    Frevert EU; Kahn BB
    Biochem J; 1996 Jun; 316 ( Pt 3)(Pt 3):865-71. PubMed ID: 8670164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1alpha,25-Dihydroxyvitamin D(3) inhibits rat liver ultrastructural changes and the development of gamma-glutamyltranspeptidase-positive foci in diethylnitrosamine-initiated and streptozotocin-induced diabetes-promoted hepatocarcinogenesis.
    Saha BK; Bhattacharya R; Chatterjee M
    Cell Biochem Funct; 2002 Sep; 20(3):195-204. PubMed ID: 12125095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promotion potential of tamoxifen on hepatocarcinogenesis in female SD or F344 rats initiated with diethylnitrosamine.
    Kim DJ; Han BS; Ahn B; Lee KK; Kang JS; Tsuda H
    Cancer Lett; 1996 Jun; 104(1):13-9. PubMed ID: 8640739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of two selenium sources on hepatocarcinogenesis and several angiogenic cytokines in diethylnitrosamine-induced hepatocarcinoma rats.
    Liu JG; Zhao HJ; Liu YJ; Liu YW; Wang XL
    J Trace Elem Med Biol; 2012 Oct; 26(4):255-61. PubMed ID: 22425635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time course of cell cycle-related protein expression in diethylnitrosamine-initiated rat liver.
    Lee YS; Kim WH; Yu ES; Kim MR; Lee MJ; Jang JJ
    J Hepatol; 1998 Sep; 29(3):464-9. PubMed ID: 9764995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1 alpha,25-Dihydroxyvitamin D(3) inhibits rat liver ultrastructural changes in diethylnitrosamine-initiated and phenobarbital promoted rat hepatocarcinogenesis.
    Basak R; Bhattacharya R; Chatterjee M
    J Cell Biochem; 2001 Mar; 81(2):357-67. PubMed ID: 11241675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biphasic modifying effect of indole-3-carbinol on diethylnitrosamine-induced preneoplastic glutathione S-transferase placental form-positive liver cell foci in Sprague-Dawley rats.
    Kim DJ; Lee KK; Han BS; Ahn B; Bae JH; Jang JJ
    Jpn J Cancer Res; 1994 Jun; 85(6):578-83. PubMed ID: 8063610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher CYP2E1 Activity Correlates with Hepatocarcinogenesis Induced by Diethylnitrosamine.
    Gao J; Wang Z; Wang GJ; Zhang HX; Gao N; Wang J; Wang CE; Chang Z; Fang Y; Zhang YF; Zhou J; Jin H; Qiao HL
    J Pharmacol Exp Ther; 2018 May; 365(2):398-407. PubMed ID: 29467309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.